ArticleFrontiers in cellular and infection microbiology2026
Gut microbiota and short-chain fatty acids in pregnant women with group B
Article in Frontiers in cellular and infection microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Group B Methods: In this prospective study, 87 pregnant women were enrolled at the Women and Children's Hospital of Xiamen University from March 2022 to October 2023 and divided into GBS-positive and GBS-negative cohorts according to their colonization status. Fecal samples were collected to complete 16S rRNA gene sequencing and fecal Short-chain fatty acids (SCFAs) content determination. The pregnancy outcomes and clinical prognosis information of the newborns were followed up. Intestinal microbiota composition and SCFAs levels were compared between GBS-positive and GBS-negative pregnant women, and their respective correlations with pregnancy and neonatal outcomes were evaluated. Results: Significant differences in the genera Conclusions: GBS colonization in late pregnancy is associated with disruptions in the gut microbiota and its metabolic profiles, particularly with lower
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.